KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Emergent BioSolutions (EBS) Curent Deferred Tax Liability: 2013

Historic Curent Deferred Tax Liability for Emergent BioSolutions (EBS) over the last 1 years, with Dec 2013 value amounting to $88,000.

Emergent BioSolutions' Curent Deferred Tax Liability was N/A to $88,000 in Q3 2014 from the same period last year, while for Sep 2014 it was $88,000, marking a year-over-year change of. This contributed to the annual value of $88,000 for FY2013, which is N/A change from last year.
As of FY2013, Emergent BioSolutions' Curent Deferred Tax Liability stood at $88,000.
In the past 5 years, Emergent BioSolutions' Curent Deferred Tax Liability registered a high of $88,000 during FY2013, and its lowest value of $88,000 during FY2013.
For the 1-year period, Emergent BioSolutions' Curent Deferred Tax Liability averaged around $88,000, with its median value being $88,000 (2013).